Poster: CML-353: Health Care Resource Utilization (HCRU) with Asciminib and Bosutinib among Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs): Results from the Multicenter, Open-Label Phase 3 ASCEMBL Trial

Details

Language :

English

ISSN :

21522650

Volume :

21

Database :

Complementary Index

Journal :

Clinical Lymphoma, Myeloma & Leukemia

Publication Type :

Academic Journal

Accession number :

152098732

Full Text :

https://doi.org/10.1016/S2152-2650(21)01411-7